Showing results 1 to 20 of 85
next >
| Publication Date | Title | Author(s) |
| May-2021 | Citizen brief: Accessing precision therapies for children and youth in Canada | Gauvreau, CI; Subasri, M; Wilson, MG; Denburg, AE |
| Feb-2024 | Citizen brief: Creating a system to support the adaptation and uptake of health-system innovations in Canada | Gauvin, François-Pierre; Wilson, MG |
| Jul-2024 | Citizen brief: Developing a Type 1 diabetes screening program in Canada | Wilson, MG; Scallan, E; Hayeems, R; Bain, T; Velez, CM |
| Apr-2019 | Citizen brief: Enhancing the delivery of comprehensive care for people living with HIV in Canada | Wilson, MG; Mattison, CA; Gao, C; Kendall, CE; Lavis, JN |
| Jan-2021 | Citizen brief: Identifying and harnessing the potential of technology in long-term care settings in Canada | Gauvin, François-Pierre; DeMaio, P; Alam, S; Drakos, A; Lavis, JN; Wilson, MG |
| Feb-2019 | Citizen brief: Preventing and managing infectious disease among people who inject drugs in Ontario | Waddell, K; Sharma, K; Wilson, MG |
| Nov-2022 | Citizen brief: Using remote-monitoring technologies to enable people to stay in their homes in Canada | Gauvin, François-Pierre; Wilson, MG; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile # 2: What is known about the spread and management of COVID-19 in non-health workplaces? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #10: What screening approaches can be used in non-healthcare settings (e.g., universities, stores and office settings) to identify people who may have COVID-19 and need to take appropriate action? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #11: What is the evidence related to playground equipment and risk of COVID-19 transmission? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Sharma, K; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #12: What insights from the available evidence and jurisdictional scans can inform who should be tested for COVID-19 and how frequently, where, by whom and with what follow-up actions should they be tested? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #13: What pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them, respectively? | Waddell, K; Wilson, MG; Bullock, HL; Evans, C; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #14: Where and with what impacts have shifts from in-person to virtual approaches occurred in the delivery of healthcare services in general and mental health and addictions services in particular? | Waddell, K; Bullock, HL; Evans, C; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Mansilla, C; Wang, Q; Bhuiya, AR; Ahmad, A; Filbey, L; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #15: What frameworks from available evidence and experiences in other countries can inform what needs to be done to plan for future waves of COVID-19? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Bhuiya, AR; Voorheis, P; Ahmad, A; Gao, C; Alam, S; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #16: What provider-led virtual-care services can be used to replace in-person care in hospital-based ambulatory care settings? | Wilson, MG; Waddell, K; Wang, Q; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Ahmad, A; Alam, S; Bhuiya, AR; Lavis, JN |
| Aug-2020 | COVID-19 rapid evidence profile #17: What evidence could support modelling scenarios related to the reopening, operation and monitoring of schools? | Wilson, MG; Waddell, K; Moat, KA; Wang, Q; Ahmad, A; Alam, S; Bhuiya, AR; Sharma, K; Lavis, JN |
| Sep-2020 | COVID-19 rapid evidence profile #18: Which types of non-medical masks are effective in community settings for reducing the spread of COVID-19 for different populations and under different conditions? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Wang, Q; Ahmad, A; Bhuiya, AR |
| Sep-2020 | COVID-19 rapid evidence profile #19: What is the risk of transmission of COVID-19 in hospital and long-term care settings, and the impacts of hospital-visitor policies? | Waddell, K; Wilson, MG; Moat, KA; Wang, Q; Gauvin, François-Pierre; Ahmad, A; Alam, S; Bhuiya, AR; Tchakerian, N; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #1: What is known about approaches to and safety of conserving, reusing, and repurposing different kinds of masks? | Wilson, MG; Gauvin, François-Pierre; Waddell, K; Moat, KA; Lavis, JN |
| Oct-2020 | COVID-19 rapid evidence profile #20: What living, full or rapid reviews have been produced that provide evidence about economic and social responses to COVID-19? | Wilson, MG; Waddell, K; Moat, KA; Wang, Q; Lavis, JN |
